BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Y, Liu Z, Guo K. Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer. Mol Cell Biochem 2012;363:93-9. [PMID: 22143536 DOI: 10.1007/s11010-011-1161-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang F, Lian M, Ma H, Feng L, Shen X, Chen J, Fang J. Identification of key genes associated with papillary thyroid microcarcinoma characteristics by integrating transcriptome sequencing and weighted gene co-expression network analysis. Gene 2022;811:146086. [PMID: 34856364 DOI: 10.1016/j.gene.2021.146086] [Reference Citation Analysis]
2 Sun L, Chen L, Zhu H, Li Y, Chen CC, Li M. FHL1 promotes glioblastoma aggressiveness through regulating EGFR expression. FEBS Lett 2021;595:85-98. [PMID: 33053208 DOI: 10.1002/1873-3468.13955] [Reference Citation Analysis]
3 Fu W, Wang K, Zhao JL, Yu HC, Li SZ, Lin Y, Liang L, Huang SY, Liang YM, Han H, Qin HY. FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J. BMC Cancer 2014;14:463. [PMID: 24952875 DOI: 10.1186/1471-2407-14-463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Wei X, Zhang H. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression. Cancer Biol Med 2020;17:270-81. [PMID: 32587768 DOI: 10.20892/j.issn.2095-3941.2019.0420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Dong C, Rao N, Du W, Gao F, Lv X, Wang G, Zhang J. mRBioM: An Algorithm for the Identification of Potential mRNA Biomarkers From Complete Transcriptomic Profiles of Gastric Adenocarcinoma. Front Genet 2021;12:679612. [PMID: 34386038 DOI: 10.3389/fgene.2021.679612] [Reference Citation Analysis]
6 Li SZ, Hu YY, Zhao JL, Zang J, Fei Z, Han H, Qin HY. Downregulation of FHL1 protein in glioma inhibits tumor growth through PI3K/AKT signaling. Oncol Lett 2020;19:3781-8. [PMID: 32382330 DOI: 10.3892/ol.2020.11476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhou L, Huang W, Yu HF, Feng YJ, Teng X. Exploring TCGA database for identification of potential prognostic genes in stomach adenocarcinoma. Cancer Cell Int 2020;20:264. [PMID: 32581654 DOI: 10.1186/s12935-020-01351-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 Yadavalli S, Jayaram S, Manda SS, Madugundu AK, Nayakanti DS, Tan TZ, Bhat R, Rangarajan A, Chatterjee A, Gowda H, Thiery JP, Kumar P. Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells. Sci Rep. 2017;7:43710. [PMID: 28262832 DOI: 10.1038/srep43710] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
9 Lin X, Zhao Y, Song WM, Zhang B. Molecular classification and prediction in gastric cancer. Comput Struct Biotechnol J 2015;13:448-58. [PMID: 26380657 DOI: 10.1016/j.csbj.2015.08.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
10 Chen Y, Xiang H, Zhang Y, Wang J, Yu G. Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer. Clin Exp Metastasis 2015;32:417-28. [DOI: 10.1007/s10585-015-9712-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
11 Zeng W, Rao N, Li Q, Wang G, Liu D, Li Z, Yang Y. Genome-wide Analyses on Single Disease Samples for Potential Biomarkers and Biological Features of Molecular Subtypes: A Case Study in Gastric Cancer. Int J Biol Sci 2018;14:833-42. [PMID: 29989098 DOI: 10.7150/ijbs.24816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Zhai JM, Yin XY, Hou X, Hao XY, Cai JP, Liang LJ, Zhang LJ. Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma. Dig Dis Sci. 2013;58:1934-1947. [PMID: 23625283 DOI: 10.1007/s10620-013-2663-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
13 Li Y, Zeng Q, Qiu J, Pang T, Ye F, Huang L, Zhang X. MiR-183-5p Promotes Proliferation, Metastasis and Angiogenesis in Breast Cancer Cells through Negatively Regulating Four and a Half LIM Protein 1. J Breast Cancer 2020;23:355-72. [PMID: 32908787 DOI: 10.4048/jbc.2020.23.e47] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang X, Wei X, Yuan Y, Sun Q, Zhan J, Zhang J, Tang Y, Li F, Ding L, Ye Q, Zhang H. Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter. J Cell Biol 2018;217:1335-51. [PMID: 29434030 DOI: 10.1083/jcb.201708064] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
15 Wang J, Huang F, Huang J, Kong J, Liu S, Jin J. Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer. Oncol Lett 2017;14:6109-16. [PMID: 29113254 DOI: 10.3892/ol.2017.6950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Liu Z, Jiang Z, Wu N, Zhou G, Wang X. Classification of gastric cancers based on immunogenomic profiling. Transl Oncol 2021;14:100888. [PMID: 33096337 DOI: 10.1016/j.tranon.2020.100888] [Reference Citation Analysis]
17 Zhi Z, Zhu H, Lv X, Lu C, Li Y, Wu F, Zhou L, Li H, Tang W. IGF2-derived miR-483-3p associated with Hirschsprung's disease by targeting FHL1. J Cell Mol Med 2018;22:4913-21. [PMID: 30073757 DOI: 10.1111/jcmm.13756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Wang Z, Zhang J, Yang B, Li R, Jin L, Wang Z, Yu H, Liu C, Mao Y, You Q. Long Intergenic Noncoding RNA 00261 Acts as a Tumor Suppressor in Non-Small Cell Lung Cancer via Regulating miR-105/FHL1 Axis. J Cancer 2019;10:6414-21. [PMID: 31772674 DOI: 10.7150/jca.32251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
19 Luo T, Zhao J, Lu Z, Bi J, Pang T, Cui H, Yang B, Li W, Wang Y, Wu S, Xue X. Characterization of long non-coding RNAs and MEF2C-AS1 identified as a novel biomarker in diffuse gastric cancer. Transl Oncol 2018;11:1080-9. [PMID: 30005210 DOI: 10.1016/j.tranon.2018.06.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
20 Das K, Chan XB, Epstein D, Teh BT, Kim KM, Kim ST, Park SH, Kang WK, Rozen S, Lee J. NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer. ESMO Open. 2016;1:e000009. [PMID: 27843583 DOI: 10.1136/esmoopen-2015-000009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
21 Xu X, Fan Z, Liang C, Li L, Wang L, Liang Y, Wu J, Chang S, Yan Z, Lv Z, Fu J, Liu Y, Jin S, Wang T, Hong T, Dong Y, Ding L, Cheng L, Liu R, Fu S, Jiao S, Ye Q. A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity. Nat Commun 2017;8:14059. [PMID: 28094252 DOI: 10.1038/ncomms14059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]